Bybee Clinton
SEC-identified person · CIK 1219043 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Lyell Immunopharma, Inc. LYEL | Officer | filed 2021 - 2026 |
| Neumora Therapeutics, Inc. NMRA | Officer | filed 2023 - 2025 |
| Boundless Bio, Inc. BOLD | Officer | filed 2024 - 2024 |
| Sana Biotechnology, Inc. SANA | Officer | filed 2021 - 2024 |
| Codiak Biosciences, Inc. CDAK | Officer | filed 2020 - 2022 |
| Vir Biotechnology, Inc. VIR | Officer | filed 2019 - 2022 |
| Beam Therapeutics Inc. BEAM | Officer | filed 2020 - 2021 |
| Karuna Therapeutics, Inc. KRTX | Officer | filed 2019 - 2021 |
| 908 Devices Inc. MASS | Officer | filed 2020 - 2020 |
| Quanterix Corp QTRX | Officer | filed 2017 - 2020 |
| Impinj INC PI | Director | filed 2016 - 2020 |
| Metacrine, Inc. MTCR | Officer | filed 2020 - 2020 |
| Denali Therapeutics Inc. DNLI | Officer | filed 2017 - 2019 |
| Syros Pharmaceuticals, Inc. SYRS | Officer | filed 2016 - 2019 |
| Q32 Bio Inc. QTTB | Officer | filed 2018 - 2019 |
| Sienna Biopharmaceuticals, Inc. SNNA | Officer | filed 2017 - 2019 |
| Gossamer Bio, Inc. GOSS | Officer | filed 2019 - 2019 |
| Twist Bioscience Corp TWST | Officer | filed 2018 - 2018 |
| Scholar Rock Holding Corp SRRK | Officer | filed 2018 - 2018 |
| Unity Biotechnology, Inc. UBX | Officer | filed 2018 - 2018 |
| Ruthigen, Inc. RTGN | Officer | filed 2015 - 2018 |
| Xtera Communications, INC. XCOM | Director | filed 2015 - 2016 |
| Phaserx, INC. PZRX | Officer | filed 2016 - 2016 |
| Juno Therapeutics, Inc. JUNO | Officer | filed 2014 - 2016 |
| Adesto Technologies Corp IOTS | Officer | filed 2015 - 2015 |
| VBI Vaccines INC. plcc | Officer | filed 2014 - 2015 |
| Sage Therapeutics, Inc. SAGE | Officer | filed 2014 - 2015 |
| Agios Pharmaceuticals, INC. AGIO | Officer | filed 2013 - 2015 |
| Bellerophon Therapeutics, Inc. BLPH | Officer | filed 2015 - 2015 |
| Receptos, Inc. RCPT | Officer | filed 2013 - 2014 |
| Achaogen, Inc. AKAO | Officer | filed 2014 - 2014 |
| Fate Therapeutics INC fate | Officer | filed 2013 - 2013 |
| Bluebird bio, Inc. BLUE | Officer | filed 2013 - 2013 |
| Kythera Biopharmaceuticals INC KYTH | Officer | filed 2012 - 2012 |
| Neurogesx Inc NGSX | Officer | filed 2007 - 2011 |
| Trubion Pharmaceuticals, Inc TRBN | Officer | filed 2006 - 2010 |
| Celebrate Express, INC. bday | Officer | filed 2008 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.